Generic makers of a lower-priced version of a highly popular drug for treating multiple sclerosis asked the Supreme Court on Monday to allow them to start selling their product next month.  However, if they are kept off of the market by court order and not allowed to compete for more than a year, they asked that the … Continue reading Generic firms seek big bond if kept off market